Clinical Risk Score for Persistent Postconcussion Symptoms Among Children With Acute Concussion in the ED

Roger Zemek1, Nick Barrowman2, Stephen B Freedman3

  • 1Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Canada.

JAMA
|March 9, 2016
PubMed

Insights

A new clinical risk score helps identify children at risk for persistent postconcussion symptoms (PPCS) after a head injury. This tool aids clinicians in stratifying risk for ongoing concussion symptoms in pediatric patients.

Area of Science:

  • Pediatric Emergency Medicine
  • Neurology
  • Clinical Risk Stratification

Background:

  • Approximately one-third of children with acute concussion develop persistent postconcussion symptoms (PPCS).
  • There is a lack of validated tools to identify children at risk for PPCS.
  • Early identification of at-risk children is crucial for timely intervention and management.

Purpose of the Study:

  • To derive and validate a clinical risk score for predicting PPCS in children presenting to the emergency department.
  • To develop a pragmatic tool for clinicians to assess PPCS risk.

Main Methods:

  • A prospective, multicenter cohort study (Predicting and Preventing Postconcussive Problems in Pediatrics [5P]) enrolled children aged 5-18 years with acute head injury.
  • Patients were enrolled within 48 hours of injury across 9 pediatric emergency departments.
  • Follow-up was conducted at 28 days post-injury to assess for PPCS using the Postconcussion Symptom Inventory.

Main Results:

  • A total of 3063 children were enrolled, with 2584 completing 28-day follow-up.
  • Persistent postconcussion symptoms (PPCS) were present in 31.0% of patients.
  • A 12-point risk score model was developed, including factors like female sex, older age, migraine history, prior concussion, headache, noise sensitivity, fatigue, slow responses, and balance errors. The model showed modest discrimination (AUC 0.71 in derivation, 0.68 in validation).

Conclusions:

  • A clinical risk score demonstrated modest ability to stratify PPCS risk in children with concussion.
  • Further external validation and assessment of clinical utility in office settings are recommended before widespread adoption.
  • The score aids in identifying children at risk for persistent postconcussion symptoms.
Abstract